Published on Web 02/04/2004
Total Synthesis of (-)-Apicularen A
Qibin Su and James S. Panek*
Contribution from the Department of Chemistry and Center for Chemical Methodology and
Library Design, Metcalf Center for Science and Engineering, 590 Commonwealth AVenue,
Boston UniVersity, Boston, Massachusetts 02215
Received August 15, 2003; E-mail: panek@chem.bu.edu
Abstract: Complete details of an asymmetric synthesis of apicularen (1) are described. The synthesis has
been accomplished using a highly diastereo- and enantioselective [4 + 2] annulation for the assembly of
the functionalized pyran core. An underdeveloped lactonization method involving an NaH promoted
transesterification of an advanced intermediate bearing an aryl cyanomethyl ester was used for the
macrolactonization step.
Introduction
Apicularen A, 1, was identified by Jansen and co-workers
during a screening of the myxobacterial genus for biologically
active metabolites.1 During this process, it was determined that
nearly all strains from the genus Chondromyces produced this
common highly cytotoxic metabolite. This compound is a
powerful inhibitor of human cancer cells, including the multi-
drug-resistant line KB-VI.2 In addition, the effects of apicularen
A on in vivo angiogenesis of bovine aortic endothelial cells
(BAECs) were investigated by Kwon and co-workers. It was
found that apicularen A exhibited potent and inhibitory effect
on the growth of BAECs without any evidence of cytotoxicity
even when concentrations were increased to 10 ng/mL. This
agent also showed inhibition of basic fibroblast growth factor
(bFGF)-induced invasion and capillary tube formation of BAECs
at low concentration. Accordingly, apicularen A represents a
novel antiangiogenic compound with potent antitumor activity.3
Structurally, this compound features a trans-hydroxypyran with
a salicylic acid residue within a 10-membered lactone, which
bears a highly unsaturated enamide side chain. This natural
product is usually found with varying amounts of its glycocon-
jugate with N-acetyl glucose, known as apicularen B. Biosyn-
thetic studies showed that they are acetate-derived polyketides
containing a glycine residue as a precursor of an enamide side
chain. Herein we report a total synthesis of apicularen A using
an enantioselective [4 + 2] dihydropyran annulation to assemble
the core of the natural product.4
Figure 1.
nection of the macrolide revealed the hydroxy-ester 4. We
reasoned this intermediate could be obtained from an asymmetric
allylation of aldehyde 5.6 This material was derived from
dihydropyran 6a, which was envisioned to result from a [4 +
2] annulation of the illustrated chiral allylsilane 7a and
salicylate-aldehyde 8a.7
Synthesis of Dihydropyran through [4 + 2] Annulation.
When we initiated a study concerning [4 + 2] annulation
between chiral allylsilanes 7 and aldehydes, we chose pheny-
lacetaldehyde as one of the reaction partners because of its loose
structural resemblance to the salicylate moiety of apicularen A.
We soon learned that the organosilanes used in this study
exhibited a turnover in the stereochemical course of the annu-
lation from our earlier studies with related crotylsilanes; for
instance, where a cis-pyran was assembled from a syn-crotyl-
silane 7d,7a a cis-pyran resulted from an anti diastereomer of
(4) For previous total syntheses of apicularen A, see: (a) Bhattacharjee, A.;
Seguil, O. R.; De Brabander, J. K. Tetrahedron Lett. 2001, 42, 1217. (b)
Nicolaou, K. C.; Kim, D. W.; Baati, R. Angew. Chem., Int. Ed. 2002, 41,
3701. For studies toward syntheses of apicularen A, see: (c) Bhattacharjee,
A.; De Brabander, J. K. Tetrahedron Lett. 2000, 41, 8069. (d) Lewis, A.;
Stefanuti, I.; Swain, S. A.; Smith, S. A.; Taylor, R. J. K. Tetrahedron Lett.
2001, 42, 5549. (e) Kuhnert, S. M.; Maier, M. E. Org. Lett. 2002, 4, 643.
(f) Lewis, A.; Stefanuti, I.; Swain, S. A.; Smith, S. A.; Taylor, R. J. K.
Org. Biomol. Chem. 2003, 1, 104. (g) Graetz, B. R.; Rychnovsky, S. D.
Org. Lett. 2003, 5, 3357.
(5) For preparation of amide side chain, 3, see: (a) Labrecque, D.; Charron,
S.; Rej, R.; Blais, C.; Lamothe, S. Tetrahedron Lett. 2001, 42, 2645. (b)
Fu¨rstner, A.; Dierske, T.; Thiel, O.; Blanda, G. Chem.sEur. J. 2001, 7,
5286. (c) Snider, B. B.; Song, F. Org. Lett. 2000, 2, 407.
(6) Jadhav, P. K.; Bhat, K. S.; Perumal, P. T.; Brown, H. C. J. Org. Chem.
1986, 51, 432.
Results and Discussion
Retrosynthesis of Apicularen A. Scheme 1 outlines our
retrosynthetic strategy for apicularen A where the first bond
disconnection relied on a vinylic substitution between vinyl
iodide 2 and unsaturated amide side chain 3.5 Further discon-
(1) Kunze, B.; Jansen, R.; Sasse, F.; Ho¨fle, G.; Reichenbach, H. J. Antibiot.
1998, 51, 1075.
(2) Jansen, R.; Kunze, B.; Reichenbach, H.; Ho¨fle, G. Eur. J. Org. Chem. 2000,
913.
(7) For related annulations, see: (a) Huang, H.; Panek, J. S. J. Am. Chem.
Soc. 2000, 122, 9836. (b) Huang, H.; Panek, J. S. Org. Lett. 2003, 5, 1991.
(c) Roush, W. R.; Dilley, G. J. Synlett 2001, SI, 955.
(3) Kwon, J. H.; Kim, D. H.; Shim, J. S.; Ahn, J. W. J. Microbiol. Biotechnol.
2002, 12, 702.
9
10.1021/ja037957x CCC: $27.50 © 2004 American Chemical Society
J. AM. CHEM. SOC. 2004, 126, 2425-2430
2425